Stiglmayer R
Fortschr Med. 1978 Oct 5;96(37):1843-5.
169 CEA-determinations in sera from 119 patients with gynecologic malignancies and 30 healthy women as controls are reported. The highest percentage of positive results was found in patients with cancer of the ovaries (62%). This result is followed by 60 per cent in cancer of the collum uteri, 50 per cent in cancer of vulva and vagina and 42 per cent in cancer of the breast. Very low CEA-titers have been found in cases with cancer of corpus uteri. This method is not reliable enough for very early detection of gynecological cancer, it may be a useful help in the supervision of cancer patients who already have been treated.
报告了对119例妇科恶性肿瘤患者血清及30名健康女性作为对照进行的169次癌胚抗原(CEA)测定。卵巢癌患者中阳性结果的比例最高(62%)。其次是子宫颈癌患者为60%,外阴和阴道癌患者为50%,乳腺癌患者为42%。子宫体癌患者的CEA滴度非常低。该方法对于妇科癌症的极早期检测不够可靠,但在对已接受治疗的癌症患者的监测中可能会有帮助。